Posts from March 2020.
To the dismay of CBD enthusiasts everywhere, the FDA recently issued a highly anticipated report on the status its efforts to develop regulations for the sale of hemp-derived CBD products. Unfortunately for the CBD industry, the report offered little in terms of policy updates for cannabidiol products and instead described the agency’s concerns and its efforts to develop regulations to safely allow use of the ingredient.
The 2018 Farm Bill legalized hemp and its derivatives containing less than .3 percent THC, thus allowing the introduction of CBD products. Today, you can find ... Read More ›
Posted in: Misc
Subscribe
Recent Posts
- Demystifying 2020’s Standard Essential Patents and FRAND Licensing Disputes
- Better Inventor Communication – Hidden Cost Savings In Patent Prosecution
- Sovereign Immunity, The 11th Amendment, and Intellectual Property
- Trouble Ahead for Global Data Exchanges: The Court of Justice of the EU Strikes Down “Privacy Shield”
- U.S. Supreme Court Sides with Booking.com in Critical Trademark Case
- Application of "Invention Concept" after New China Patent Examination Guidelines
- Remdesivir Versus Designated Survivor: Life Imitating Art
- Supreme Court Finds ‘Willfulness’ Not Required To Obtain A Profits Award From An Infringer
- Approaches to Cost Containment in the Time of Coronavirus
- Pharma Formulations – Patentability and Obviousness
Archives
- October 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- November 2019
- October 2019
- September 2019
- June 2019
- April 2019
- February 2019
- January 2019
- October 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- August 2017
- July 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017